Related Experiment Videos
Elevated GGTP/SGOT ratio. An early indicator of infantile obstructive cholangiopathy
Insights
Early diagnosis of biliary atresia in infants is crucial. A specific liver enzyme ratio can help identify biliary obstruction, prompting timely surgical intervention for better outcomes.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Neonatal Medicine
Background:
- Extrahepatic biliary atresia requires early surgical intervention for improved infant prognosis.
- Distinguishing biliary atresia from neonatal hepatitis is critical for appropriate management.
Purpose of the Study:
- To evaluate the utility of the serum gamma-glutamyl transpeptidase to SGOT ratio in differentiating extrahepatic biliary atresia from neonatal hepatitis in infants.
- To determine the sensitivity of this ratio in early-stage diagnosis.
Main Methods:
- Analysis of serum gamma-glutamyl transpeptidase and SGOT levels in infants diagnosed with extrahepatic biliary atresia and neonatal hepatitis.
- Calculation of the ratio of gamma-glutamyl transpeptidase to SGOT for diagnostic comparison.
Main Results:
- An elevated gamma-glutamyl transpeptidase to SGOT ratio was observed in infants with infantile obstructive cholangiopathy, including those with extrahepatic biliary atresia.
- This ratio showed potential as a sensitive indicator, being evident as early as 5 to 14 days of age in biliary atresia cases.
- Elevated ratios were also noted in alpha 1-antitrypsin deficiency with bile duct proliferation.
Conclusions:
- The gamma-glutamyl transpeptidase to SGOT ratio may serve as a sensitive marker for biliary obstruction in infants.
- An elevated ratio strongly suggests biliary obstruction, warranting early surgical evaluation (laparotomy) for definitive diagnosis and treatment.
Abstract:
Early surgical intervention in cases of extrahepatic biliary atresia improves prognosis. The ratio of serum gamma-glutamyl transpeptidase to SGOT is elevated in infants with infantile obstructive cholangiopathy. This appears to be a sensitive method for distinguishing infants with extrahepatic biliary atresis from those with neonatal hepatitis. This distinction was evident as early as 5 to 14 days of age and was clearly manifest in ten of 12 infants with biliary atresia. The ratio was also elevated in patients with alpha 1-antitrypsin deficiency who had bile duct proliferation. We do not claim that the ratio can clearly distinguish extrahepatic biliary atresia from neonatal hepatitis, but we do suggest that an elevation raises a strong presumption of biliary obstruction and invites early consideration of laparotomy and examination of the biliary tree.